Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Endoscopic treatment of vesicoureteral reflux in pediatric patients

  • Kim, Jong Wook (Department of Urology, Korea University Guro Hospital) ;
  • Oh, Mi Mi (Department of Urology, Korea University Guro Hospital)
  • Received : 2012.09.12
  • Accepted : 2012.11.02
  • Published : 2013.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently approved by the U.S. Food and Drug Administration for treating VUR. Endoscopic treatment of VUR has gained great popularity owing to several obvious benefits, including short operative time, short hospital stay, minimal invasiveness, high efficacy, low complication rate, and reduced cost. Initially, the success rates of endoscopic treatment have been lower than that of open antireflux surgery. However, because injection techniques have been developed, a recent study showed higher success rates of endoscopic treatment than open surgery in the treatment of patients with intermediate- and high-grade VUR. Despite the controversy surrounding its effectiveness, endoscopic treatment is considered a valuable treatment option and viable alternative to long-term antibiotic prophylaxis.

Keywords

References

  1. Tekgul S, Riedmiller H, Hoebeke P, Kocvara R, Nijman RJ, Radmayr C, et al. European Association of Urology. EAU guidelines on vesicoureteral reflux in children. Eur Urol 2012;62:534-42. https://doi.org/10.1016/j.eururo.2012.05.059
  2. Skoog SJ, Peters CA, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Pediatric vesicoureteral reflux guidelines panel summary report: clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates/infants with prenatal hydronephrosis. J Urol 2010;184:1145-51. https://doi.org/10.1016/j.juro.2010.05.066
  3. Peters CA, Skoog SJ, Arant BS Jr, Copp HL, Elder JS, Hudson RG, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 2010;184:1134-44. https://doi.org/10.1016/j.juro.2010.05.065
  4. Routh JC, Bogaert GA, Kaefer M, Manzoni G, Park JM, Retik AB, et al. Vesicoureteral reflux: current trends in diagnosis, screening, and treatment. Eur Urol 2012;61:773-82. https://doi.org/10.1016/j.eururo.2012.01.002
  5. Skoog SJ. Prophylaxis versus no prophylaxis for reflux. J Urol 2012;187:1161-2. https://doi.org/10.1016/j.juro.2012.01.023
  6. Hensle TW, Grogg AL, Eaddy M. Pediatric vesicoureteral reflux: treatment patterns and outcomes. Nat Clin Pract Urol 2007;4:462-3.
  7. Stokland E, Hellstrom M, Jacobsson B, Jodal U, Sixt R. Renal damage one year after first urinary tract infection: role of dimercaptosuccinic acid scintigraphy. J Pediatr 1996;129:815-20. https://doi.org/10.1016/S0022-3476(96)70024-0
  8. Oh MM, Jin MH, Bae JH, Park HS, Lee JG, Moon du G. The role of vesicoureteral reflux in acute renal cortical scintigraphic lesion and ultimate scar formation. J Urol 2008;180:2167-70. https://doi.org/10.1016/j.juro.2008.07.067
  9. Duckett JW, Walker RD, Weiss R. Surgical results: International Reflux Study in Children--United States branch. J Urol 1992;148:1674-5. https://doi.org/10.1016/S0022-5347(17)36999-9
  10. Elder JS, Peters CA, Arant BS Jr, Ewalt DH, Hawtrey CE, Hurwitz RS, et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol 1997;157:1846-51. https://doi.org/10.1016/S0022-5347(01)64882-1
  11. Matouschek E. New concept for the treatment of vesico-ureteral reflu:. endoscopic application of Teflon. Arch Esp Urol 1981;34:385-8.
  12. O'Donnell B, Puri P. Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 1984;289:7-9. https://doi.org/10.1136/bmj.289.6436.7
  13. Lendvay TS, Sorensen M, Cowan CA, Joyner BD, Mitchell MM, Grady RW. The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database study. J Urol 2006;176:1864-7. https://doi.org/10.1016/j.juro.2006.04.088
  14. Nelson CP, Copp HL, Lai J, Saigal CS; Urologic Diseases in America Project. Is availability of endoscopy changing initial management of vesicoureteral reflux? J Urol 2009;182:1152-7. https://doi.org/10.1016/j.juro.2009.05.049
  15. Sorensen MD, Koyle MA, Cowan CA, Zamilpa I, Shnorhavorian M, Lendvay TS. Injection volumes of dextranomer/hyaluronic acid are increasing in the endoscopic management of vesicoureteral reflux. Pediatr Surg Int 2010;26:509-13. https://doi.org/10.1007/s00383-010-2558-9
  16. Chertin B, Kocherov S, Chertin L, Natsheh A, Farkas A, Shenfeld OZ, et al. Endoscopic bulking materials for the treatment of vesicoureteral reflux: a review of our 20 years of experience and review of the literature. Adv Urol 2011;2011:309626.
  17. Vandenbossche M, Delhove O, Dumortier P, Deneft F, Schulman CC. Endoscopic treatment of reflux: experimental study and review of Teflon and collagen. Eur Urol 1993;23:386-93. https://doi.org/10.1159/000474636
  18. Aaronson IA, Rames RA, Greene WB, Walsh LG, Hasal UA, Garen PD. Endoscopic treatment of reflux: migration of Teflon to the lungs and brain. Eur Urol 1993;23:394-9. https://doi.org/10.1159/000474637
  19. Haferkamp A, Contractor H, Mohring K, Staehler G, Dorsam J. Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term followup. Urology 2000;55:759-63. https://doi.org/10.1016/S0090-4295(00)00494-5
  20. Kershen RT, Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin North Am 1999;26:81-94. https://doi.org/10.1016/S0094-0143(99)80008-1
  21. Herz D, Hafez A, Bagli D, Capolicchio G, McLorie G, Khoury A. Efficacy of endoscopic subureteral polydimethylsiloxane injection for treatment of vesicoureteral reflux in children: a North American clinical report. J Urol 2001;166:1880-6. https://doi.org/10.1016/S0022-5347(05)65712-6
  22. Solomon LZ, Birch BR, Cooper AJ, Davies CL, Holmes SA. Nonhomologous bioinjectable materials in urology: 'size matters'? BJU Int 2000;85:641-5.
  23. Smith DP, Kaplan WE, Oyasu R. Evaluation of polydimethylsiloxane as an alternative in the endoscopic treatment of vesicoureteral reflux. J Urol 1994;152:1221-4. https://doi.org/10.1016/S0022-5347(17)32552-1
  24. Henly DR, Barrett DM, Weiland TL, O'Connor MK, Malizia AA, Wein AJ. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 1995;153:2039-43. https://doi.org/10.1016/S0022-5347(01)67398-1
  25. Sanger JR, Matloub HS, Yousif NJ, Komorowski R. Silicone gel infiltration of a peripheral nerve and constrictive neuropathy following rupture of a breast prosthesis. Plast Reconstr Surg 1992;89:949-52. https://doi.org/10.1097/00006534-199205000-00029
  26. Caldamone AA, Diamond DA. Long-term results of the endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes. J Urol 2001;165:2224-7. https://doi.org/10.1016/S0022-5347(05)66170-8
  27. Onol FF, Tarcan T, Tinay I, Kotiloglu E, Simsek F. Kidney loss due to periureteral fibrosis and ureteral obstruction secondary to migration of subureterically injected calcium hydroxylapatite. J Pediatr Urol 2006;2:503-8. https://doi.org/10.1016/j.jpurol.2005.10.006
  28. Tarcan T, Tinay I, Temiz Y, Simsek F. Long-term results of endoscopic treatment of vesicoureteral reflux with the sub-ureteric injection of calcium hydroxyapatite. Int Urol Nephrol 2007;39:1011-4. https://doi.org/10.1007/s11255-007-9222-x
  29. Stenberg A, Lackgren G. A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 1995;154:800-3. https://doi.org/10.1016/S0022-5347(01)67168-4
  30. Puri P, Chertin B, Velayudham M, Dass L, Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 2003;170:1541-4. https://doi.org/10.1097/01.ju.0000083924.44779.80
  31. Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC. The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 2004;171:2413-6. https://doi.org/10.1097/01.ju.0000127754.79866.7f
  32. Chertin B, Colhoun E, Velayudham M, Puri P. Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup. J Urol 2002;167:1443-5. https://doi.org/10.1016/S0022-5347(05)65340-2
  33. Lackgren G, Wahlin N, Skoldenberg E, Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2001;166:1887-92. https://doi.org/10.1016/S0022-5347(05)65713-8
  34. Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ. Intermediate to long-term follow-up indicates low risk of recurrence after double HIT endoscopic treatment for primary vesico-ureteral reflux. J Pediatr Urol 2012;8:359-65. https://doi.org/10.1016/j.jpurol.2011.07.006
  35. Cerwinka WH, Scherz HC, Kirsch AJ. Dynamic hydrodistention classification of the ureter and the double hit method to correct vesicoureteral reflux. Arch Esp Urol 2008;61:882-7.
  36. Kirsch AJ, Kaye JD, Cerwinka WH, Watson JM, Elmore JM, Lyles RH, et al. Dynamic hydrodistention of the ureteral orifice: a novel grading system with high interobserver concordance and correlation with vesicoureteral reflux grade. J Urol 2009;182:1688-92. https://doi.org/10.1016/j.juro.2009.02.061
  37. Stenberg A, Hensle TW, Lackgren G. Vesicoureteral reflux: a new treatment algorithm. Curr Urol Rep 2002;3:107-14. https://doi.org/10.1007/s11934-002-0020-9
  38. Elmore JM, Kirsch AJ, Lyles RH, Perez-Brayfield MR, Scherz HC. New contralateral vesicoureteral reflux following dextranomer/hyaluronic acid implantation: incidence and identification of a high risk group. J Urol 2006;175:1097-100. https://doi.org/10.1016/S0022-5347(05)00405-2
  39. Chertin B, Puri P. Endoscopic management of vesicoureteral reflux: does it stand the test of time? Eur Urol 2002;42:598-606. https://doi.org/10.1016/S0302-2838(02)00447-5
  40. Kobelt G, Canning DA, Hensle TW, Lackgren G. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2003;169:1480-4. https://doi.org/10.1097/01.ju.0000056638.75652.54
  41. Stenberg A, Lackgren G. Treatment of vesicoureteral reflux in children using stabilized non-animal hyaluronic acid/dextranomer gel (NASHA/DX): a long-term observational study. J Pediatr Urol 2007;3:80-5. https://doi.org/10.1016/j.jpurol.2006.08.001
  42. Heidenreich A, Ozgur E, Becker T, Haupt G. Surgical management of vesicoureteral reflux in pediatric patients. World J Urol 2004;22:96-106.
  43. Ogan K, Pohl HG, Carlson D, Belman AB, Rushton HG. Parental preferences in the management of vesicoureteral reflux. J Urol 2001;166:240-3. https://doi.org/10.1016/S0022-5347(05)66135-6
  44. Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R, et al. Endoscopic therapy for vesicoureteral reflux: a metaanalysis. I. Reflux resolution and urinary tract infection. J Urol 2006;175:716-22. https://doi.org/10.1016/S0022-5347(05)00210-7
  45. Molitierno JA, Scherz HC, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. J Pediatr Urol 2008;4:221-8. https://doi.org/10.1016/j.jpurol.2007.11.015
  46. Puri P, Kutasy B, Colhoun E, Hunziker M. Single center experience with endoscopic subureteral dextranomer/hyaluronic acid injection as first line treatment in 1,551 children with intermediate and high grade vesicoureteral reflux. J Urol 2012;188:1485-9. https://doi.org/10.1016/j.juro.2012.02.023
  47. Dave S, Lorenzo AJ, Khoury AE, Braga LH, Skeldon SJ, Suoub M, et al. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. J Urol 2008;180:1594-9. https://doi.org/10.1016/j.juro.2008.03.084
  48. Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 2010;125:1010-9. https://doi.org/10.1542/peds.2009-2225
  49. Fonseca FF, Tanno FY, Nguyen HT. Current options in the management of primary vesicoureteral reflux in children. Pediatr Clin North Am 2012;59:819-34. https://doi.org/10.1016/j.pcl.2012.05.012
  50. Kirsch AJ, Perez-Brayfield MR, Scherz HC. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. J Urol 2003;170:211-5. https://doi.org/10.1097/01.ju.0000072523.43060.a0
  51. Lorenzo AJ, Pippi Salle JL, Barroso U, Cook A, Grober E, Wallis MC, et al. What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 2006;176:1851-5. https://doi.org/10.1016/S0022-5347(06)00599-4
  52. Chi A, Gupta A, Snodgrass W. Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 2008;179:1966-9. https://doi.org/10.1016/j.juro.2008.01.054
  53. Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E. Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 2006;176:1856-9. https://doi.org/10.1016/j.juro.2006.03.124
  54. Holmdahl G, Brandstrom P, Lackgren G, Sillen U, Stokland E, Jodal U, et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol 2010;184:280-5. https://doi.org/10.1016/j.juro.2010.01.059
  55. Kirsch AJ. Injection therapy for reflux: why it works and why it fails. J Urol 2012;188:16-7. https://doi.org/10.1016/j.juro.2012.04.035
  56. Garin EH, Olavarria F, Garcia Nieto V, Valenciano B, Campos A, Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 2006;117:626-32. https://doi.org/10.1542/peds.2005-1362
  57. Montini G, Rigon L, Zucchetta P, Fregonese F, Toffolo A, Gobber D, et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics 2008;122:1064-71. https://doi.org/10.1542/peds.2007-3770
  58. Roussey-Kesler G, Gadjos V, Idres N, Horen B, Ichay L, Leclair MD, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol 2008;179:674-9.

Cited by

  1. Vesicoureteral Reflux: Current Management in Children vol.15, pp.10, 2014, https://doi.org/10.1007/s11934-014-0447-9
  2. Intraoperative contrast-enhanced urosonography during endoscopic treatment of vesicoureteral reflux in children vol.44, pp.9, 2014, https://doi.org/10.1007/s00247-014-2963-7
  3. Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux vol.44, pp.6, 2018, https://doi.org/10.1590/s1677-5538.ibju.2018.0033
  4. Endoscopic Injection of Bulking Agents for the Treatment of Vesicoureteral Reflux and Introducing a New Material: Acellular Lyophilized Prepuce as a Natural Scaffold vol.30, pp.3, 2013, https://doi.org/10.5812/ijp.100970